Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions.

INTRODUCTION: Lipodystrophy syndromes are a heterogeneous group of rare disorders characterized by partial or generalized loss of adipose tissue, which may be either inherited or acquired. Loss of adipose tissue in typical storage sites starting from…

Preview only. Read the full abstract at the source